UPDATE: Amneal Pharmaceuticals (AMRX) Tops Q1 EPS by 2c, Revenues Miss; Offers FY21 Revenues Outlook

Go back to UPDATE: Amneal Pharmaceuticals (AMRX) Tops Q1 EPS by 2c, Revenues Miss; Offers FY21 Revenues Outlook
AmerElite Solutions, Inc. New (NASDAQ: AMRX) Delayed: 13.52 +0.64 (4.97%)
Previous Close $12.88    52 Week High $0.19 
Open $13.00    52 Week Low $0.07 
Day High $13.69    P/E N/A 
Day Low $13.00    EPS $-0.01 
Volume 1,743,141